NCT03900949 2026-05-15Gentuzumab Ozogamicin and Midostaurin Combination With Standard Cytarabine and Danunorubi Midostaurin as a Novel Approach to Treating Patients With Newly Diagnosed FLT-3 Mutated Acute Myeloid LeukemiaOhio State University Comprehensive Cancer CenterPhase 1 Completed21 enrolled